Raymond James Financial Portfolio holdings
Raymond James Financial, founded in 1962 by Robert James and headquartered in St. Petersburg, Florida, is a diversified financial services firm managing over $1.5 trillion in client assets as of late 2024, primarily focused on wealth management, investment banking, and brokerage services. Known for its advisor-centric model, the firm supports over 8,900 financial advisors across the U.S., Canada, and the UK, offering personalized financial planning, retirement solutions, and investment products to individuals, small businesses, and institutions. Its investment banking arm specializes in middle-market mergers, acquisitions, and equity offerings, while its Raymond James Bank provides lending and deposit services. With a reputation for a conservative, client-first culture and steady growth—including a notable acquisition of TriState Capital in 2022—Raymond James stands out as a resilient, relationship-driven player in the financial industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Expanded Tech Sector ETF
IGM
|
+$271M |
| 2 |
Analog Devices
ADI
|
+$262M |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$190M |
| 4 |
Roblox
RBLX
|
+$174M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$167M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$361M |
| 2 |
iShares Expanded Tech-Software Sector ETF
IGV
|
+$221M |
| 3 |
Netflix
NFLX
|
+$164M |
| 4 |
Oracle
ORCL
|
+$155M |
| 5 |
Aptus Collared Investment Opportunity ETF
ACIO
|
+$140M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.83% |
| 2 | Financials | 8.91% |
| 3 | Industrials | 6.89% |
| 4 | Healthcare | 6.26% |
| 5 | Consumer Discretionary | 6.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4726
Wave Life Sciences
WVE
$1.04B
| $115K | ﹤0.01% |
15,687
-1,117
| -7% | -$9.04K |
|
4727
Xponential Fitness
XPOF
$209M
| $115K | ﹤0.01% |
14,732
+2,500
| +20% | +$22.8K |
|
|
ORC
4728
Orchid Island Capital
ORC
$1.32B
| $114K | ﹤0.01% |
16,234
+8,391
| +107% | +$59.7K |
|
4729
Candel Therapeutics
CADL
$859M
| $113K | ﹤0.01% |
22,164
| – | – |
|
4730
PUT
Sphere Entertainment
SPHR
$6.08B
| $113K | ﹤0.01% |
+3,000
| New | +$142K |
|
4731
CALL
Tesla
TSLA
$1.35T
| $112K | ﹤0.01% |
400
-900
| -69% | -$312K |
|
4732
374Water
SCWO
$44.3M
| $112K | ﹤0.01% |
39,024
+740
| +2% | +$2.02K |
|
4733
TriplePoint Venture Growth BDC
TPVG
$220M
| $111K | ﹤0.01% |
19,284
+151
| +0.8% | +$1K |
|
|
GRFS
4734
Grifois
GRFS
$5.34B
| $109K | ﹤0.01% |
10,976
+380
| +4% | +$3.8K |
|
|
BHR
4735
Braemar Hotels & Resorts
BHR
$140M
| $109K | ﹤0.01% |
40,000
-13,900
| -26% | -$35.1K |
|
4736
PUT
Marathon Petroleum
MPC
$99.4B
| $109K | ﹤0.01% |
+700
| New | +$123K |
|
4737
PUT
Palantir
PLTR
$420B
| $109K | ﹤0.01% |
700
-1,100
| -61% | -$178K |
|
4738
PUT
Jabil
JBL
$37.8B
| $108K | ﹤0.01% |
+600
| New | +$131K |
|
|
LAND
4739
Gladstone Land Corp
LAND
$357M
| $105K | ﹤0.01% |
11,445
+471
| +4% | +$4.45K |
|
4740
Telomir Pharmaceuticals
TELO
$76.3M
| $105K | ﹤0.01% |
75,340
+73,547
| +4,102% | +$111K |
|
4741
Altimmune
ALT
$568M
| $104K | ﹤0.01% |
27,672
+1,703
| +7% | +$6.58K |
|
4742
Douglas Elliman
DOUG
$185M
| $104K | ﹤0.01% |
36,236
+4,019
| +12% | +$10.5K |
|
|
MGRM
4743
DELISTED
Monogram Orthopaedics
MGRM
| $104K | ﹤0.01% |
17,643
+11,252
| +176% | +$60.1K |
|
4744
Outdoor Holding Co
POWW
$263M
| $103K | ﹤0.01% |
69,587
+49,477
| +246% | +$65.9K |
|
4745
PUT
ConocoPhillips
COP
$153B
| $102K | ﹤0.01% |
+1,200
| New | +$113K |
|
4746
Cytosorbents Corp
CTSO
$24.8M
| $102K | ﹤0.01% |
108,721
+132
| +0.1% | +$130 |
|
4747
Array Technologies
ARRY
$784M
| $99.2K | ﹤0.01% |
12,175
-4,706
| -28% | -$35.6K |
|
4748
SEACOR Marine Holdings
SMHI
$266M
| $97.8K | ﹤0.01% |
15,065
+10,000
| +197% | +$60.6K |
|
4749
Opko Health
OPK
$1.04B
| $96.4K | ﹤0.01% |
62,205
-3,965
| -6% | -$5.45K |
|
4750
Acco Brands
ACCO
$398M
| $96K | ﹤0.01% |
24,048
-10,958
| -31% | -$42.7K |
|
Similar funds
Raymond James Financial's Q3 2025 Portfolio in Review
As of Q3 2025, Raymond James Financial held 7,043 positions worth $311B, up 7.1% from $290B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Raymond James Financial's Q3 2025 filing shows 115 new, 2,686 increased, 2,015 reduced and 2,063 closed positions. Its largest new stake was BNY Mellon Dynamic Value ETF: 747,224 shares worth $20.8M. The largest sale was Broadcom, an estimated $361M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Financials and Industrials.
- Raymond James Financial's largest Q3 2025 buy was BNY Mellon Dynamic Value ETF: 747,224 shares worth $20.8M.
- Raymond James Financial added most to iShares Expanded Tech Sector ETF in Q3 2025, an estimated $271M increase.
- Raymond James Financial's biggest Q3 2025 reduction was Broadcom, cutting an estimated $361M.
- Raymond James Financial fully exited Inspire Medical Systems in Q3 2025, selling an estimated $29.9M.
- Raymond James Financial's ten largest holdings make up 22% of its $311B portfolio in Q3 2025.
- Raymond James Financial opened 115 new positions and closed 2,063 in Q3 2025.
- Raymond James Financial's portfolio value rose 7.1% quarter-over-quarter to $311B.
Based on Raymond James Financial's 13F filing for Q3 2025, filed 14 Nov 2025.